Evidence map›Paper›PMID 40794023›Full record

ArticleMolecular carcinogenesis2025

Uncovering the Role of DNA Repair Impairment in UVA-Induced Mutagenesis in Human Xeroderma Pigmentosum Variant Cells.

Camila Corradi, Natália Cestari Moreno, Nathalia Quintero-Ruiz, Giovana da Silva Leandro, Marcela Teatin Latancia, Tiago Antonio de Souza, Veridiana Munford, Carlos Frederico Martins Menck

Abstract read
In one paragraph

Article in Molecular carcinogenesis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Camila CorradiLaboratory of DNA Repair, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.ORCID 0000-0002-2587-7576
Natália Cestari MorenoDepartment of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Nathalia Quintero-RuizFaculty of Applied Science, Campinas University, Limeira, SP, Brazil.
Giovana da Silva LeandroLaboratory of DNA Repair, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.
Marcela Teatin LatanciaLaboratory of Genomic Integrity, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-3743-7105
Tiago Antonio de SouzaTauGC Bioinformatics, São Paulo, SP, Brazil.
Veridiana MunfordLaboratory of DNA Repair, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.
Carlos Frederico Martins MenckLaboratory of DNA Repair, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.

Funding

This study was supported by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).
6 · The paper itself

Abstract

Ultraviolet A (UVA) radiation induces DNA damage both directly, by forming cyclobutane pyrimidine dimers (CPDs), and indirectly, by generating oxidative stress. Cells rely on nucleotide excision repair (NER) and translesion synthesis (TLS) to tolerate these lesions. Xeroderma pigmentosum variant (XP-V) cells, deficient in DNA polymerase eta (pol eta), exhibit a heightened risk of skin cancer due to impaired TLS. While XP-V patients are considered NER-proficient, our findings challenge this assumption by demonstrating that UVA-induced oxidative stress impaired NER activity, leading to increased C > T transitions at CPD sites. Whole-exome sequencing of UVA-irradiated XP-V cells revealed a substantial rise in mutations, with a distinct C > T signature characteristic of defective CPD repair. Notably, pretreatment with the antioxidant N-acetylcysteine (NAC) mitigated this effect, reducing C > T transitions through enhanced NER function and decreasing C > A transversions via its antioxidant properties. These results redefine the mutagenic landscape of XP-V cells, revealing that oxidatively generated damage to NER proteins-rather than TLS deficiency alone-contributes to their elevated mutation burden. Our findings suggest that antioxidant strategies may partially protect XP-V patients from UVA-driven mutagenesis enhancing the cells' DNA repair capacity, ultimately reducing skin cancer and contributing to better overall health outcomes.

Indexed as

DNA RepairMutagenesisSkin NeoplasmsUltraviolet RaysXeroderma PigmentosumAcetylcysteineDNA DamageDNA-Directed DNA PolymeraseExome SequencingHumansMutationOxidative StressPyrimidine DimersY-Family DNA PolymerasesAcetylcysteineDNA-Directed DNA PolymerasePyrimidine DimersRad30 proteinY-Family DNA PolymerasesDNA polymerase etanucleotide excision repairoxidative stresspyrimidine dimersultraviolet A

Identifiers

PMID40794023
PMCPMC12535409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.